Dr. Reddy's Laboratories

$68.08
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.47 (+0.70%) As of 2:30 PM EDT today

Why Robinhood?

You can buy or sell RDY and other stocks, options, and ETFs commission-free!

About RDY

Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. Read More It operates through the following segments: Global Generics, Pharmaceutical Services and Active Ingredients, Proprietary Products, and Others. The Global Generics segment consists of manufacturing and marketing of prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name or as generic finished dosages with therapeutic equivalence to branded formulations. The Pharmaceutical Services and Active Ingredients segment is comprised of manufacturing and marketing of active pharmaceutical ingredients and intermediates, also known as API or bulk drugs, which are principal ingredients for finished pharmaceutical products. The Proprietary Products segment focuses on research, development, and manufacture of differentiated formulations and new chemical entities. The Others segment includes the operations of the wholly-owned subsidiary of the company, Aurigene Discovery Technologies Limited, a discovery stage biotechnology company developing novel and best-in-class therapies in the fields of oncology and inflammation and which works with pharmaceutical and biotechnology companies in early-stage collaborations, brining drug candidates for pre-clinical development. The company was founded by Kallam Anji Reddy on February 24, 1984 and is headquartered in Hyderabad, India. The listed name for RDY is Dr. Reddy's Laboratories Limited American Depositary Shares.

Employees
21,650
Headquarters
Hyderabad, Telangana
Founded
1984
Market Cap
11.30B
Price-Earnings Ratio
44.16
Dividend Yield
0.40
Average Volume
185.48K
High Today
$68.17
Low Today
$67.80
Open Price
$67.91
Volume
110.10K
52 Week High
$73.50
52 Week Low
$33.33

Collections

RDY News

Reuters12h

Data breach prompts India's Dr Reddy's to shut key plants: ET Now

BENGALURU (Reuters) - A data breach at Dr Reddy’s Laboratories Ltd prompted the Indian drugmaker to shut its key plants globally, television channel ET Now repo

RDY Earnings

$0.00
$0.31
$0.62
$0.93
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Q4 2020
Q1 2021
Q2 2021
Estimated
per share
Actual
Available Oct 28, Pre-Market

You May Also Like